Data gathered: January 2
Alternative Data for Eyepoint Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 8 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 8 | Sign up | Sign up | Sign up |
| Patents | 15 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,528 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,640 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,409 | Sign up | Sign up | Sign up |
| Twitter Mentions | 10 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 60 | Sign up | Sign up | Sign up |
| Linkedin Employees | 190 | Sign up | Sign up | Sign up |
About Eyepoint Pharmaceuticals
EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders.
| Price | $8.03 |
| Target Price | Sign up |
| Volume | 1,130,000 |
| Market Cap | $508M |
| Year Range | $7.02 - $19.94 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Up 5.8% – What’s Next?January 2 - ETF Daily News |
|
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Purchased by Geode Capital Management LLCJanuary 2 - ETF Daily News |
|
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $25.71 Average PT from AnalystsDecember 20 - ETF Daily News |
|
Charles Schwab Investment Management Inc. Purchases 7,967 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)December 18 - ETF Daily News |
|
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Sees Large Decline in Short InterestDecember 18 - ETF Daily News |
|
EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Up 7% – What’s Next?December 8 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 11M | 14M | -3.2M | -29M | -33M | 0.000 |
| Q2 '24 | 9.5M | 14M | -4.7M | -31M | -34M | -0.580 |
| Q1 '24 | 12M | 15M | -3.2M | -29M | -33M | -0.550 |
| Q4 '23 | 14M | 11M | 2.8M | -14M | -16M | -0.330 |
| Q3 '23 | 15M | 11M | 4.2M | -13M | -13M | -0.330 |
Insider Transactions View All
| ANDO GORAN filed to buy 13,150 shares at $8. August 21 '24 |
| DICICCO WENDY F filed to buy 9,967 shares at $7.8. August 21 '24 |
| Zaderej Karen L. filed to buy 16,500 shares at $8. August 21 '24 |
| Lurker Nancy filed to buy 97,635 shares at $7.9. August 20 '24 |
| GUYER DAVID R filed to sell 1,850 shares at $10.1. July 16 '24 |
Similar companies
Read more about Eyepoint Pharmaceuticals (EYPT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eyepoint Pharmaceuticals?
The Market Cap of Eyepoint Pharmaceuticals is $508M.
What is the current stock price of Eyepoint Pharmaceuticals?
Currently, the price of one share of Eyepoint Pharmaceuticals stock is $8.03.
How can I analyze the EYPT stock price chart for investment decisions?
The EYPT stock price chart above provides a comprehensive visual representation of Eyepoint Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eyepoint Pharmaceuticals shares. Our platform offers an up-to-date EYPT stock price chart, along with technical data analysis and alternative data insights.
Does EYPT offer dividends to its shareholders?
As of our latest update, Eyepoint Pharmaceuticals (EYPT) does not offer dividends to its shareholders. Investors interested in Eyepoint Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Eyepoint Pharmaceuticals?
Some of the similar stocks of Eyepoint Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.